Yuteng Zeng

Jiangsu Key Laboratory Of Drug Discovery And Translational Research For Brain Diseases
Suzhou, 215123, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein.

Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein.

Journal: Acta biomaterialia

Published: November 17, 2025

GRP94 mediates blood-brain barrier permeation and substantia nigra-specific drug distribution in Parkinson's disease.

GRP94 mediates blood-brain barrier permeation and substantia nigra-specific drug distribution in Parkinson's disease.

Journal: Colloids and surfaces. B, Biointerfaces

Published: December 03, 2024

Biomimetic membrane-coated nanoparticles specially permeate the inflammatory blood-brain barrier to deliver plasmin therapy for brain metastases.

Biomimetic membrane-coated nanoparticles specially permeate the inflammatory blood-brain barrier to deliver plasmin therapy for brain metastases.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 05, 2024

Brain-tumor-seeking and serpin-inhibiting outer membrane vesicles restore plasmin-mediated attacks against brain metastases.

Brain-tumor-seeking and serpin-inhibiting outer membrane vesicles restore plasmin-mediated attacks against brain metastases.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 30, 2024

A novel BODIPY-based theranostic agent for in vivo fluorescence imaging of cerebral Aβ and ameliorating Aβ-associated disorders in Alzheimer's disease transgenic mice.

A novel BODIPY-based theranostic agent for in vivo fluorescence imaging of cerebral Aβ and ameliorating Aβ-associated disorders in Alzheimer's disease transgenic mice.

Journal: RSC medicinal chemistry

Published: December 27, 2023

Suppressing Wnt signaling of the blood‒tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases.

Suppressing Wnt signaling of the blood‒tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases.

Journal: Acta pharmaceutica Sinica. B

Published: November 07, 2023

Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy.

Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 22, 2023

DH5α Outer Membrane-Coated Biomimetic Nanocapsules Deliver Drugs to Brain Metastases but not Normal Brain Cells via Targeting GRP94.

DH5α Outer Membrane-Coated Biomimetic Nanocapsules Deliver Drugs to Brain Metastases but not Normal Brain Cells via Targeting GRP94.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: January 14, 2023

Recent advances in biomedical applications of bacterial outer membrane vesicles.

Recent advances in biomedical applications of bacterial outer membrane vesicles.

Journal: Journal of materials chemistry. B

Published: July 06, 2022

Biomimetic Lipopolysaccharide-Free Bacterial Outer Membrane-Functionalized Nanoparticles for Brain-Targeted Drug Delivery.

Biomimetic Lipopolysaccharide-Free Bacterial Outer Membrane-Functionalized Nanoparticles for Brain-Targeted Drug Delivery.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 16, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026